Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. It offers QRX003, a topical lotion to treat Netherton Syndrome QRX004 показать больше
for the treatment dystrophic epidermolysis bullosa and QRX006, a therapy to treat rare skin disease. The company was incorporated in 2018 and is based in Ashburn, Virginia.
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. It offers QRX003, a topical lotion to treat Netherton Syndrome QRX004 for the treatment dystrophic epidermolysis bullosa and QRX006, a therapy to treat rare skin disease. The company was incorporated in 2018 and is based in Ashburn, Virginia.
– моментальные уведомления о рынке акций
